Search





Search





Markets
/
Stocks
/
aura
/

Aura Biosciences Inc

AURA

Add to Watchlist

7.155USD

+0.105+1.49%

Close 07-27 16:00（ET）Quotes delayed by 15 min

450.66MMarket Cap

LossP/E TTM

Aura Biosciences Inc

7.155

+0.105+1.49%

Financial Summary Income Statement Balance Sheet Cash Flow Statement

Overview

Financials

Discussions

Analysis

Company

Financial Summary Income Statement Balance Sheet Cash Flow Statement

AURA Cash Flow Statement

You can access the annual and quarterly cash flow statements of Aura Biosciences Inc to evaluate its financial soundness and stability.

Quarterly

Quarterly+Annual

Quarterly

Annual

YOY

Hide blank rows

FY2026Q1

FY2025Q4

FY2025Q3

FY2025Q2

FY2025Q1

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021Q4

FY2021Q3

FY2020Q4

FY2020Q3

Operating cash flows (indirect method)

Cash flow from continuing operating activities

-27.99%-29.89M

14.54%-20.47M

-31.89%-20.14M

-28.81%-20.77M

4.49%-23.36M

-37.76%-23.95M

0.84%-15.27M

-10.13%-16.13M

-48.99%-24.45M

3.48%-17.39M

-43.15%-15.40M

-37.80%-14.64M

-7.97%-16.41M

-49.04%-18.01M

-23.82%-10.76M

---10.63M

---15.20M

-221.69%-12.09M

-31.43%-8.69M

---3.76M

---6.61M

Net income from continuing operations

-22.57%-33.69M

1.06%-25.56M

-24.18%-26.13M

-32.86%-27.02M

-39.47%-27.48M

-16.73%-25.83M

-13.67%-21.04M

-11.14%-20.34M

-12.82%-19.71M

-33.65%-22.13M

-16.42%-18.51M

-35.87%-18.30M

-36.08%-17.47M

-42.33%-16.56M

-79.92%-15.90M

---13.47M

---12.84M

-137.09%-11.63M

-143.40%-8.84M

---4.91M

---3.63M

Operating gains losses

-5.84%274.00K

-6.53%272.00K

-10.54%280.00K

-8.63%286.00K

-4.90%291.00K

-10.19%291.00K

-8.75%313.00K

4.33%313.00K

-6.71%306.00K

0.31%324.00K

13.58%343.00K

1.35%300.00K

28.13%328.00K

40.43%323.00K

39.81%302.00K

--296.00K

--256.00K

1.77%230.00K

-6.90%216.00K

--226.00K

--232.00K

Other non-cash items

220.00%120.00K

94.55%-22.00K

108.18%55.00K

110.37%99.00K

91.36%-100.00K

4.72%-404.00K

-82.61%-672.00K

-102.76%-955.00K

-29.82%-1.16M

-262.39%-424.00K

-843.59%-368.00K

-241.30%-471.00K

-9811.11%-892.00K

---117.00K

-2050.00%-39.00K

---138.00K

---9.00K

--0.00

100.00%2.00K

----

--1.00K

Change in working capital

-200.71%-426.00K

265.39%1.56M

-41.89%1.96M

17.51%2.03M

106.22%423.00K

-146.31%-942.00K

318.07%3.38M

-8.92%1.73M

-2206.10%-6.80M

153.95%2.03M

-76.67%808.00K

30.17%1.89M

93.06%-295.00K

-88.78%-3.77M

705.42%3.46M

--1.46M

---4.25M

-366.98%-2.00M

83.20%-572.00K

--748.00K

---3.41M

-Change in prepaid expenses

-42.49%1.73M

731.29%2.68M

-66.02%-1.53M

-110.13%-121.00K

180.08%3.00M

-181.73%-425.00K

-4.88%-924.00K

-27.49%1.20M

-263.61%-3.75M

114.19%520.00K

-167.61%-881.00K

114.58%1.65M

238.07%2.29M

-21.77%-3.66M

235.45%1.30M

--768.00K

---1.66M

-2562.83%-3.01M

-732.89%-962.00K

---113.00K

--152.00K

-Change in other current assets

-108.88%-46.00K

60.81%-194.00K

-121.85%-92.00K

-2155.56%-185.00K

825.00%518.00K

-381.25%-495.00K

2706.67%421.00K

111.69%9.00K

128.00%56.00K

141.61%176.00K

--15.00K

---77.00K

---200.00K

---423.00K

----

Cash from non-recurring investing activities

Cash from operating activities

-27.99%-29.89M

14.54%-20.47M

-31.89%-20.14M

-28.81%-20.77M

4.49%-23.36M

-37.76%-23.95M

0.84%-15.27M

-10.13%-16.13M

-48.99%-24.45M

3.48%-17.39M

-43.15%-15.40M

-37.80%-14.64M

-7.97%-16.41M

-49.04%-18.01M

-23.82%-10.76M

---10.63M

---15.20M

-221.69%-12.09M

-31.43%-8.69M

---3.76M

---6.61M

Investing cash flow

Net cash from continuing investing activities

-45.45%102.00K

-41.14%176.00K

-86.80%45.00K

-92.57%39.00K

112.50%187.00K

-5.68%299.00K

278.89%341.00K

172.02%525.00K

-19.27%88.00K

-11.45%317.00K

42.86%90.00K

160.81%193.00K

-81.80%109.00K

-56.29%358.00K

-89.01%63.00K

--74.00K

--599.00K

520.45%819.00K

467.33%573.00K

--132.00K

--101.00K

Capital expenditures

-45.45%102.00K

-41.14%176.00K

-86.80%45.00K

-92.57%39.00K

112.50%187.00K

-5.68%299.00K

278.89%341.00K

172.02%525.00K

-19.27%88.00K

-11.45%317.00K

42.86%90.00K

160.81%193.00K

-81.80%109.00K

-56.29%358.00K

-89.01%63.00K

--74.00K

--599.00K

520.45%819.00K

467.33%573.00K

--132.00K

--101.00K

Net cash flow from disposal of fixed assets

-45.45%102.00K

-41.14%176.00K

-86.80%45.00K

-92.57%39.00K

112.50%187.00K

-5.68%299.00K

278.89%341.00K

172.02%525.00K

-19.27%88.00K

-11.45%317.00K

42.86%90.00K

160.81%193.00K

-81.80%109.00K

-56.29%358.00K

-89.01%63.00K

--74.00K

--599.00K

520.45%819.00K

467.33%573.00K

--132.00K

--101.00K

Net cash flow from investment products

83.33%55.00M

0.02%30.00M

-529.85%-43.97M

-1.72%20.02M

216.32%30.00M

133.40%29.99M

-52.90%10.23M

-5.71%20.37M

114.20%9.48M

-443.67%-89.80M

20.60%21.72M

149.81%21.60M

-168.16%-66.77M

---16.52M

--18.01M

---43.37M

---24.90M

----

Net cash flow from other investing activities

--0.00

----

Cash from non-current investing activities

Net cash flow from investing activities

84.14%54.90M

0.43%29.82M

-545.13%-44.02M

0.69%19.98M

217.29%29.81M

132.95%29.70M

-54.28%9.89M

-7.32%19.84M

114.05%9.40M

-434.01%-90.12M

20.52%21.63M

149.28%21.41M

-162.29%-66.88M

-1960.56%-16.88M

3231.94%17.95M

---43.44M

---25.50M

-520.45%-819.00K

-467.33%-573.00K

---132.00K

---101.00K

Financing cash flow

Cash flow from continuous financing activities

212.50%300.00K

409.58%2.77M

509.36%4.36M

84151.81%69.93M

-62.06%96.00K

-99.42%543.00K

-55.97%716.00K

-96.65%83.00K

25.87%253.00K

-2.33%92.98M

1463.46%1.63M

701.94%2.48M

1082.35%201.00K

18.79%95.20M

109.32%104.00K

--309.00K

--17.00K

1461.31%80.14M

-123.25%-1.12M

--5.13M

--4.80M

Net cash flow from debt Issuance/repayment

----

---34.00K

----

Net cash flow from common stock issuance/repurchase

----

--2.77M

--0.00

--55.77M

----

-100.00%0.00

----

-2.71%92.62M

--1.35M

--1.82M

----

20.97%95.20M

----

--78.70M

----

Net cash flow from preferred stock issuance/repurchase

----

--0.00

-100.00%0.00

--5.06M

--4.85M

Proceeds from stock option exercised by employees

--56.00K

-100.00%0.00

58.99%1.01M

-97.59%2.00K

-100.00%0.00

47.15%543.00K

213.86%634.00K

-87.42%83.00K

8.97%158.00K

--369.00K

94.23%202.00K

113.59%660.00K

752.94%145.00K

-100.00%0.00

420.00%104.00K

--309.00K

--17.00K

193.33%44.00K

11.11%20.00K

--15.00K

--18.00K

Proceeds from issuance of warrants

--123.00K

--0.00

--14.16M

----

Net cash flow from other financing activities

26.04%121.00K

--0.00

3991.46%3.35M

--0.00

1.05%96.00K

--0.00

13.89%82.00K

--0.00

69.64%95.00K

--0.00

--72.00K

--0.00

--56.00K

-100.00%0.00

100.00%0.00

----

--0.00

1390.43%1.40M

-1570.59%-1.14M

--94.00K

---68.00K

Net cash from non-recurrent financing activities

Net cash from financing activities

212.50%300.00K

409.58%2.77M

509.36%4.36M

84151.81%69.93M

-62.06%96.00K

-99.42%543.00K

-55.97%716.00K

-96.65%83.00K

25.87%253.00K

-2.33%92.98M

1463.46%1.63M

701.94%2.48M

1082.35%201.00K

18.79%95.20M

109.32%104.00K

--309.00K

--17.00K

1461.31%80.14M

-123.25%-1.12M

--5.13M

--4.80M

Net cash flow

Beginning cash balance

85.71%60.28M

84.61%48.32M

250.60%108.14M

44.17%38.99M

-22.43%32.46M

-53.57%26.18M

-36.43%30.84M

-31.14%27.05M

-65.80%41.85M

-9.17%56.37M

-11.41%48.52M

-63.81%39.28M

-17.99%122.37M

-24.29%62.06M

-40.69%54.77M

--108.53M

--149.21M

404.67%81.97M

408.64%92.35M

--16.24M

--18.16M

Current period cash flow changes

286.93%25.28M

90.30%11.96M

-1181.36%-59.81M

1721.42%69.14M

144.13%6.53M

143.29%6.29M

-159.45%-4.67M

-58.92%3.80M

82.18%-14.80M

-124.08%-14.52M

7.71%7.85M

117.19%9.24M

-104.25%-83.09M

-10.30%60.31M

170.24%7.29M

---53.76M

---40.68M

5304.90%67.24M

-442.27%-10.38M

--1.24M

---1.91M

Effect of exchange rate changes

-28.57%-27.00K

---160.00K

---14.00K

--9.00K

---21.00K

----

Ending cash balance

119.42%85.56M

85.71%60.28M

84.61%48.32M

250.60%108.14M

44.17%38.99M

-22.43%32.46M

-53.57%26.18M

-36.43%30.84M

-31.14%27.05M

-65.80%41.85M

-9.17%56.37M

-11.41%48.52M

-63.81%39.28M

-17.99%122.37M

-24.29%62.06M

--54.77M

--108.53M

753.27%149.21M

404.67%81.97M

--17.49M

--16.24M

Free cash flow

-27.41%-30.00M

14.87%-20.64M

-29.30%-20.19M

-24.98%-20.81M

4.07%-23.54M

-36.98%-24.25M

-0.78%-15.61M

-12.23%-16.65M

-48.54%-24.54M

3.63%-17.70M

-43.15%-15.49M

-38.65%-14.84M

-4.57%-16.52M

-42.36%-18.37M

-16.84%-10.82M

---10.70M

---15.80M

-231.83%-12.90M

-37.99%-9.26M

---3.89M

---6.71M

Currency unit

--USD

Audit opinions

----

FAQs

What is operating cash flow?



Operating cash flow is the cash generated or used by a company's core business operations. It adjusts net income for non-cash items and working capital changes, such as depreciation, receivables, inventory, and payables. Strong operating cash flow can indicate that the business is converting sales and earnings into real cash.

How Much Operating Cash Flow Did Aura Biosciences Inc Generate?



Aura Biosciences Inc generated -84.74M in operating cash flow in fiscal 2025, reflecting cash generated from its core business operations.

How Did Aura Biosciences Inc's Operating Cash Flow Change Year Over Year?



Aura Biosciences Inc's operating cash flow increased by -6.19% year over year.

What is investing cash flow?



Investing cash flow shows cash used for or generated from investment-related activities, such as capital expenditures, purchases or sales of investments, acquisitions, and asset disposals. Negative investing cash flow is not always bad, because it can reflect spending on future growth, but investors should check whether those investments support long-term returns.

How Much Does Aura Biosciences Inc Spend on Capital Expenditures?



Aura Biosciences Inc spent 447.00K on capital expenditures in the most recent quarter。

What is financing cash flow?



Financing cash flow shows how a company raises capital or returns capital to investors and creditors. It can include debt issuance, debt repayment, share issuance, share repurchases, dividend payments, and lease financing. Positive financing cash flow may show new capital raised, while negative financing cash flow may reflect debt repayment, dividends, or buybacks.

How Has Aura Biosciences Inc's Financing Cash Flow Changed?



Aura Biosciences Inc used 77.16M in financing activities in the latest quarter.

What is free cash flow and why does it matter for AURA?



Free cash flow is the cash a company has left after funding the capital spending needed to maintain or grow the business. It is often used to assess financial flexibility, debt repayment capacity, dividend sustainability, buyback potential, and valuation quality. Investors should compare free cash flow with net income, revenue growth, and capital expenditures.

What was Aura Biosciences Inc’s free cash flow in the latest quarter?



Free cash flow was -85.19M reflecting a -5.10% change from the previous year.